Bath & Body Works Soars 12.6% After Beating Earnings Estimates and Updating Guidance for Fiscal 2024

Bath & Body Works, Inc. (NYSE: BBWI) has delivered an impressive performance in its third-quarter results, eclipsing analysts' forecasts and sending shares soaring by 12.6% in premarket activity.

The prominent personal care and home fragrance retailer reported adjusted earnings per share (EPS) of $0.49, comfortably surpassing the consensus estimate of $0.47. This solid performance was also accompanied by quarterly revenues reaching $1.61 billion, exceeding expectations of $1.58 billion and showcasing a year-over-year growth of 3%.

The driving force behind this notable success appears to be the company’s robust product innovation and strategic investments in both marketing and technology, as highlighted by CEO Gina Boswell.

In light of these favorable results, Bath & Body Works has updated its guidance for the full fiscal year 2024. The company now anticipates that net sales will contract by between 2.5% and 1.7% compared to fiscal 2023, which is a notable shift from earlier estimates. A revised projection for full-year adjusted EPS has been set between $3.15 and $3.28.

As the company looks ahead to the fourth quarter, it expects net sales to decline between 6.5% and 4.5% year over year, influenced by a 500 basis point headwind stemming from a shift in the fiscal calendar. The forecast for earnings per share during this crucial period ranges from $1.94 to $2.07. These projections also factor in an expected $400 million allocated for share repurchases throughout the year.

For stock traders, these developments may signal a promising recovery trajectory for Bath & Body Works, especially as the adjustments in guidance and strategy indicate a company willing to adapt to market dynamics. With increased consumer interest in personal care products, traders might want to keep a close watch on BBWI as it navigates the remainder of the fiscal year.